Emerson Lucena da Silva

7PUBLICATIONS
13CO-AUTHORS
Haematological tumoursMolecular targetsAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 09, 2023
PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia.

Caio Bezerra Machado, Emerson Lucena da Silva, Wallax Augusto Silva Ferreira

|Sep 23, 2022
Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer.

Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Emerson Lucena da Silva

|Jul 28, 2022
1,4-Naphthoquinone (CNN1) Induces Apoptosis through DNA Damage and Promotes Upregulation of H2AFX in Leukemia Multidrug Resistant Cell Line.

Adrhyann Jullyanne de Sousa Portilho, Emerson Lucena da Silva, Emanuel Cintra Austregésilo Bezerra

|Apr 12, 2022
Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution.

Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Emerson Lucena da Silva

|Oct 23, 2021
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.

Caio Bezerra Machado, Flávia Melo Cunha de Pinho Pessoa, Emerson Lucena da Silva

Pageof 2